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Background: Radiation is the most commonly used cancer treatment and has recently been shown to
enhance the effectiveness of immune-based therapies. The most effective immunotherapy strategies
generate tumor-associated antigen (TAA) specific cytotoxic T-cells (CTLs) capable of killing tumor cells.
We have previously shown enhanced killing of colorectal carcinoma cells by tumor-specific CD8+ CTLs
following sub-lethal tumor irradiation in vitro. Tumor cells, however, can induce a variety of
immunosuppressive mechanisms, including the induction of CD4+ regulatory T cells (TREGS). TREGS are
capable of directly inhibiting anti-tumor attack by CTLs, resulting in tumor escape from immune
elimination. More recently we have seen changes in the expression of genes that are known to alter the
function of both CTLs and TREGS. In addition, we have a funded grant to explore the impact of irradiated
tumor cells on TREG function. Identifying therapies that could reverse induction of TREG cells is
essential to improving immunotherapy strategies. The goal of this study is to determine if gene
expression patterns exist that correlate with increased CTL activity and decreased TREGS function. We
hypothesize that exposure of tumor cells to sub-lethal doses of IR will induce a molecular signature of
enhanced immunogenicity that results in decreased TREG activity and increased CTL activity. A major
objective of this study is to identify a set of radiation-induced molecules in tumor cells that correlate
with altered immune cell activity.
Methods: Changes in gene expression will be evaluated using standard flow cytometry (for protein) and
q-RT-PCR (for mRNA) methods. Experiments will help identify a set of candidate molecular markers that
can discriminate between cancer cells killed by CTLs and those that are not following IR. To achieve this
we will investigate if there is a relationship between immune cell function (CTL killing of tumor cells or
TREG cell suppressive activity) and a gene expression pattern. To determine concordance among cell
lines post-IR, protein and mRNA expression signatures will be analyzed using linear regression. For this
analysis, gene expression will be transformed into fold-change of irradiated (10Gy or 5Gy) versus 0Gy
and normalized to input cell numbers. Immune cell function will also be reported as fold-change to
describe increases in CTL activity (and decreases in TREG activity) following tumor irradiation
Results: We analyzed data from the following cell cultures: Colo205, HCT116, and SW620 that were in
the following irradiation conditions: 0Gy, 5Gy and 10Gy. We first determined the changes from baseline
in the higher irradiation conditions, that is, we computed differences in the gene expression from 0Gy to
5Gy, and from 0Gy to 10Gy. A treatment is deemed to be significant if the slope is significantly different
from 0. For Colo205 cells, we have obtained a value of β = 0.365 for the slope, corresponding to a pvalue of 0.718; we conclude that this effect is not statistically significant. For the HCT116 cells, we
obtained β = 1.555 and p = 0.139. For the SW620 cells we obtained β = 1.777 and p = 0.090. The data
for the HCT116 and SW620 cells is fairly close to being statistically significant at α = 0.1.
Future directions: We plan to collect additional data points for these cell lines in order to validate our
results at α = 0.05. Results of the proposed research will expand information available regarding
immune relevant molecular changes induced in carcinoma cells following IR and facilitate progress
towards achieving the long-term goal of elucidating the mechanistic link between IR and increased
tumor attack by CTLs.

